Europe - Euronext Oslo - OSL:LIFE - NO0013355859 - Common Stock
The current stock price of LIFE.OL is 0.738 NOK. In the past month the price decreased by -85.81%. In the past year, price decreased by -94.05%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.67 | 109.18B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 19.46 | 52.46B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.17 | 24.47B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.18 | 24.49B | ||
| BIM.PA | BIOMERIEUX | 29.25 | 13.36B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 150 | 4.51B | ||
| DIA.MI | DIASORIN SPA | 21.93 | 4.06B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 25.63 | 3.69B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 11.66 | 1.41B | ||
| ELN.MI | EL.EN. SPA | 22.86 | 1.18B | ||
| DRW8.DE | DRAEGERWERK AG | 9.55 | 1.16B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 25.11 | 1.04B |
Lifecare ASA engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland and currently employs 28 full-time employees. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
LIFECARE ASA
Ytrebygdsvegen 215
Bergen HORDALAND NO
Employees: 32
Phone: 4740059040
Lifecare ASA engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland and currently employs 28 full-time employees. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
The current stock price of LIFE.OL is 0.738 NOK. The price decreased by -4.65% in the last trading session.
LIFE.OL does not pay a dividend.
LIFE.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
LIFECARE ASA (LIFE.OL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-16.64).
You can find the ownership structure of LIFECARE ASA (LIFE.OL) on the Ownership tab.
ChartMill assigns a fundamental rating of 3 / 10 to LIFE.OL. The financial health of LIFE.OL is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months LIFE.OL reported a non-GAAP Earnings per Share(EPS) of -16.64. The EPS decreased by -40.55% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -93.35% | ||
| ROE | -124.42% | ||
| Debt/Equity | 0.12 |
null analysts have analysed LIFE.OL and the average price target is 36.72 NOK. This implies a price increase of 4875.61% is expected in the next year compared to the current price of 0.738.
For the next year, analysts expect an EPS growth of 8.12% and a revenue growth -75% for LIFE.OL